Short answer

Ayahuasca cannot be called safe for everyone. Serious complications were rare in selected controlled trial participants, but nausea, vomiting, transient increases in heart rate and blood pressure, anxiety, and disorientation were reported regularly. The evidence is less representative of people with coexisting conditions, concurrent substance use, or exposure to preparations of unknown composition. Risk therefore needs to be assessed carefully for each person.

What does "relatively well tolerated" mean in research?

The phrase "relatively well tolerated" describes the outcome of a particular protocol: how many people completed the study, what adverse events they experienced, and whether they required intervention. It is not a general guarantee. Participants are usually pre-selected, screened for health status, observed in a controlled environment, and administered a preparation of known composition.

This design is useful for identifying typical acute reactions. At the same time, it excludes many people who may be more vulnerable. If a serious event did not occur among several dozen participants, this does not prove that it is impossible. Much larger datasets and reliable post-exposure follow-up are needed to assess rare events.

Safety reviews combine controlled studies, observational studies, and case reports. These sources answer different questions. A controlled study records the composition and timing more precisely, but includes a narrow group of participants. Reports from the real world cover more situations, but often lack laboratory confirmation of composition and complete medical information.

Adverse reactions are common

Nausea and vomiting are among the most frequently described physical reactions. Scientific studies describe them as adverse events or physiological reactions; they do not establish that vomiting is evidence of "cleansing". Diarrhea, tremors, dizziness, weakness, headache, and temporary changes in heart rate and blood pressure have also been reported.

The psychological picture is no less important. Possible reactions include intense fear, confusion, panic, a sense of losing control and severe disorientation. Some people evaluate the experience positively, but one person’s positive account cannot predict how another will respond. A detailed description of various subjective and physical reactions can be found in the article about the effects of ayahuasca.

  • nausea, vomiting, diarrhea, or stomach pain;
  • temporary increase in heart rate and blood pressure;
  • tremors, weakness, dizziness, or headache;
  • fear, panic, confusion or severe disorientation;
  • difficulty falling asleep and exhaustion after the acute phase.

The frequency of the reaction and its severity are different indicators. A common phenomenon may be moderate in most observations, but severe in an individual. A rare phenomenon can have serious consequences. Therefore, a list of percentages without a description of intensity and context gives an incomplete picture.

Rare but serious events

Serious event in studies means an outcome that is life-threatening, requires hospitalization, causes significant impairment of function, or requires emergency intervention. This definition is not the same as a subjectively "very difficult experience", although both situations deserve attention.

Reviews and toxicology publications describe psychotic and manic episodes, convulsions, severe cardiovascular reactions, and impaired consciousness in isolated cases. It is difficult to establish causality: sometimes the composition is unknown, other substances are present, or there is a lack of data on the previous state. Uncertainty about the cause does not make a report unimportant, but it limits the conclusions that can be drawn.

A small number of reports does not tell us how common these events are. We often do not know how many people were exposed in total, how systematically the information was collected, and how many events were not reported. That is why the statement "serious cases are rare" should be read with the caveat of incomplete reporting.

Physical and mental factors of vulnerability

Psychological reactions may be particularly unpredictable if there is a personal or family history of psychosis or mania. A review of descriptions of psychotic episodes does not allow for an absolute diagnostic list, but consistently draws attention to prior vulnerability, other substances, and intense context.

Physiological vulnerability is related to the fact that an acute reaction can alter pulse, blood pressure, temperature, consciousness and coordination. Risk is not determined by a single test or questionnaire. It depends on a combination of conditions, current symptoms, substances in the body and the ability to quickly recognize deterioration.

A separate uncertainty is created by chemical variability. The article about the composition of ayahuasca explains why the common name does not guarantee the same alkaloids and concentrations. If a particular preparation has not been analyzed, data from a controlled study cannot accurately describe its profile.

Why participant selection changes the safety picture

Participant selection is one of the main reasons why the results cannot be mechanically generalized to everyone. The study group may exclude people with certain cardiovascular, neurological, and psychiatric conditions, as well as with potentially significant combinations of substances. After such selection, the complication rate is expected to be lower.

Studies of experienced users are also subject to healthy-participant bias. People who have previously had a severe reaction may not return and be excluded from the sample. Those who continue to participate do not necessarily reflect people trying ayahuasca for the first time or the wider population.

A controlled setting allows researchers to monitor physiological measurements and respond to changes. This is part of the protocol, not a property of the drug itself. Data on acute phase duration also come mainly from such structured conditions.

Why the setting and supervision matter

Physical space does not eliminate pharmacologic risk, but it does affect how quickly disorientation, falls, overheating, or altered consciousness are noticed. What is important is not the decor and atmosphere, but competent observation and the ability to call for professional help.

Empty bright room with a plant near the window

Expectations and group dynamics can change how a person reports symptoms. If a strong response is called mandatory or helpful in advance, the participant may be slower to recognize deterioration. A careful account of safety does not romanticize physical distress or treat every difficult reaction as beneficial.

When urgent help is needed

Emergency care is required when signs of immediate danger appear: loss of consciousness, seizures, severe difficulty breathing, severe chest pain, dangerously high fever, sudden confusion, or behavior that poses a risk of injury. These are general signals for urgent professional evaluation, not a way to determine the cause yourself.

After the acute phase, symptoms that persist or markedly interfere with sleep, orientation, contact with reality, or daily functioning also require professional evaluation. The name of the substance should not delay seeking care. It is important to inform the medical team of the known composition and time of exposure without concealing other substances.

How to read safety numbers

The percentage of adverse events makes sense only together with the denominator. One case in a group of twenty people and ten cases in two hundred give the same five percent but different certainty of the result. In a small sample, one additional event changes the proportion dramatically. Therefore, next to the percentage, you should look for the absolute number of participants.

Next, you need to distinguish any unwanted phenomenon from a serious one. A study may report a high incidence of nausea but no hospitalization; another may report few events overall, but one with serious consequences. A summary of "adverse reactions rarely occurred" without severity categories may obscure an important difference.

The third question is causality. An event after an exposure is not automatically caused by it alone. The authors evaluate the temporal relationship, alternative explanations, other substances and antecedents. If there is little information, the appropriate conclusion may be "a link is possible" or "the link cannot be assessed". Indeterminate causation is neither the same as proven causation nor the complete absence of a relationship.

Finally, the length of follow-up is important. A same-day protocol is good at capturing acute changes, but may miss problems with sleep or mental status later. The survey after a month sees a longer period, but is more dependent on memory and willingness to answer. A more complete picture emerges when different sources converge and their limitations are stated directly.

It is also useful to check who collected the reports and how they asked the questions. An open-ended survey captures what participants consider important, but may miss symptoms they did not think worth mentioning. The standardized list is more systematic, but its wording affects the answers. A registry with active follow-up usually detects more events than a passive system that relies on people reporting events themselves. It is incorrect to compare their percentages without accounting for these methodological differences. Therefore, a well-conducted review does not reduce all numbers to one rating, but explains the origin of each data set and the level of confidence in it.

What is confirmed and what we do not know

Available studies fairly consistently show common acute gastrointestinal, cardiovascular, and psychological reactions. In the selected healthy participants of controlled studies, most reactions resolved during the observation period. The mechanism by which beta-carbolines interact with MAO-A helps explain why other substances may modify risk; the basic explanation is in the article about the mechanism of action.

Much less well known are the exact rates of rare severe events, the consequences for people with multiple co-morbid conditions, and the profile of unknown botanical mixtures. Self-reports are useful for detecting signals, but do not always confirm composition and causality. Controlled trials are more precise in detail, but not large enough for rare risks.

A useful account of safety describes the known reactions, explains who was studied and acknowledges the gaps in the evidence. Those gaps make an unconditional promise of safety scientifically unjustified.

Sources

  1. Systematic review of adverse events associated with ayahuasca (2024).
  2. Ayahuasca and the risk of psychosis: a systematic review (2017).
  3. A review of current data on the safety of ayahuasca (2024).
  4. Toxicological aspects and health risks of ayahuasca (2019).